| | | | | | | |
 | CSL LIMITED | 0.65% | 5.96% | -6.10% | -4.25% | 26.49% | 90 814 |
 | SAMSUNG BIOLOGICS CO.,LTD. | -3.01% | -1.83% | -10.74% | -5.06% | 157.10% | 45 825 |
 | WUXI BIOLOGICS (CAYMAN) INC. | -0.71% | 15.22% | -17.18% | -46.13% | 237.67% | 41 498 |
 | BIOGEN INC. | 0.24% | 5.05% | -11.46% | -37.57% | -11.40% | 31 038 |
 | CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. | 8.20% | 7.83% | -12.56% | -39.39% | 156.78% | 24 084 |
 | UCB | 0.05% | 3.11% | -19.30% | -8.50% | 12.79% | 16 152 |
| BIOMARIN PHARMACEUTICAL INC. | -1.64% | 14.16% | -3.31% | 1.18% | 1.67% | 16 067 |
| WALVAX BIOTECHNOLOGY CO., LTD. | 0.86% | 0.81% | -14.06% | -21.08% | 75.64% | 11 466 |
 | GRIFOLS, S.A. | 3.37% | 3.52% | 13.51% | -16.13% | -24.02% | 11 300 |
| BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED | 3.49% | -4.43% | -9.21% | -47.55% | --.--% | 9 798 |
| SHANGHAI JUNSHI BIOSCIENCES CO., LTD. | -0.11% | 0.22% | -22.59% | -32.68% | 50.92% | 9 381 |
| CELLTRION HEALTHCARE CO., LTD. | 0.88% | 11.75% | -14.59% | -39.14% | 30.37% | 8 160 |
| SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD. | 2.98% | 2.35% | -29.21% | -52.47% | 38.91% | 7 092 |
| INNOVENT BIOLOGICS, INC. | -1.80% | 34.39% | -26.42% | -60.25% | 36.28% | 6 755 |
 | SWEDISH ORPHAN BIOVITRUM AB (PUBL) | 1.24% | 5.03% | 18.85% | 44.69% | 24.33% | 6 334 |
| | | | | | | |
| | Moyenne | 0.98% | 6.88% | -10.96% | -24.29% | 58.11% | |
| | Moyenne pondérée par Capi. | 0.52% | 6.24% | -10.36% | -20.19% | 77.06% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
